ANALOG OF GLP-1 OF FORMULA I OR ITS COMPOSITION, ANALOG OF GLP-1 OF FORMULA V OR ITS COMPOSITION, ANALOG OF GLP-1 OF FORMULA VI OR ITS COMPOSITION, ANALOG OF GLP-1 OF FORMULA VII OR ITS COMPOSITION, ANALOG OF FORMULA VII GLP-1 OF FORMULA VIII OR ITS COMPOSITION, ANALOG OF GLP-1 OF FORMULA IX OR ITS COMPOSITION, COMPOUND, PHARMACEUTICAL COMPOSITION, AND, USE OF A COMPOUND
The present invention relates to novel analogs of glucagon like peptide and compositions that are useful for up-regulating insulin expression in mammals and for treating diabetes. In particular, these peptide derivatives have a peptide mimic linker and provides long duration of action for the treatment of diabetes and other insulinotropic peptide related diseases, gastrointestinal function and activities associated with glucagon levels.